Peter F. Zipfel

Active 1989–2025

157
Papers
24,169
Citations
99
h-index
155
i10-index

Citations

Citations per year for Peter F. Zipfel1900: 1 citations1989: 7 citations1990: 18 citations1991: 15 citations1992: 7 citations1993: 19 citations1994: 37 citations1995: 10 citations1996: 21 citations1997: 29 citations1998: 57 citations1999: 108 citations2000: 65 citations2001: 119 citations2002: 136 citations2003: 128 citations2004: 147 citations2005: 161 citations2006: 246 citations2007: 284 citations2008: 287 citations2009: 345 citations2010: 369 citations2011: 300 citations2012: 404 citations2013: 413 citations2014: 213 citations2015: 247 citations2016: 318 citations2017: 161 citations2018: 166 citations2019: 613 citations2020: 654 citations2021: 608 citations2022: 457 citations2023: 329 citations2024: 522 citations2025: 236 citations2026: 4 citations1901–1988: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,665 citing papers, 25% of this breakdownGermany: 676 citing papers, 10.2% of this breakdownUnited Kingdom: 577 citing papers, 8.7% of this breakdownChina: 392 citing papers, 5.9% of this breakdownFrance: 335 citing papers, 5% of this breakdownItaly: 322 citing papers, 4.8% of this breakdownNetherlands: 246 citing papers, 3.7% of this breakdownSpain: 217 citing papers, 3.3% of this breakdownSweden: 182 citing papers, 2.7% of this breakdownSwitzerland: 164 citing papers, 2.5% of this breakdownCanada: 162 citing papers, 2.4% of this breakdownAustralia: 156 citing papers, 2.3% of this breakdown
0%25%Other 23.5%

Fields

  • Immunology and Microbiology40.5%
  • Medicine40.4%
  • Biochemistry, Genetics and Molecular Biology11.6%
  • Neuroscience3.5%
  • Nursing1.1%
  • Agricultural and Biological Sciences1%
  • Other1.9%

Topics

  • Complement system in diseases12%
  • Renal Diseases and Glomerulopathies5.7%
  • Retinal Diseases and Treatments2.6%
  • Antifungal resistance and susceptibility2.5%
  • Blood groups and transfusion2.2%
  • Fungal Infections and Studies1.6%
  • Other73.4%

Coauthors

All papers

Open in search
  1. Complement regulators and inhibitory proteins

    Authors: , - Nature reviews. Immunology 2009 cited by 1,265

  2. Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Daniel P. Gale, Hermann Haller, Sally Johnson, Mihály Józsi, Diana Karpman, Lynne D. Lanning, Moglie Le Quintrec, Christoph Licht, Chantal Loirat, Francisco Monfort, B. Paul Morgan, Laure-Hélène Noël, Michelle M. O’Shaughnessy, Marion Rabant, Éric Rondeau, Piero Ruggenenti, Neil Sheerin, Jenna L.H. Smith, Fabrizio Spoleti, Joshua M. Thurman, Nicole C. A. J. van de Kar, Marina Vivarelli, Peter F. Zipfel - Kidney International 2016 cited by 695

  3. C3 glomerulopathy — understanding a rare complement-driven renal disease

    Authors: , , , , , , , , , , , , , , , , , - Nature Reviews Nephrology 2019 cited by 396

  4. ApoE attenuates unresolvable inflammation by complex formation with activated C1q

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2019 cited by 316

  5. The classical pathway triggers pathogenic complement activation in membranous nephropathy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2023 cited by 97

  6. The role of complement in kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nina Görlich, Mark Haas, Alister Humphreys, Vivekanand Jha, Arenn Jauhal, David Kavanagh, Andreas Kronbichler, Richard Lafayette, Lynne D. Lanning, Mathieu Lemaire, Moglie Le Quintrec, Christoph Licht, Adrian Liew, Steve McAdoo, Nicholas Medjeral‐Thomas, Pier Luigi Meroni, Johann Morelle, Carla Nester, Manuel Praga, Raja Ramachandran, Heather N. Reich, Giuseppe Remuzzi, Santiago Rodrı́guez de Córdoba, Gary Robinson, Pierre Ronco, Peter Rossing, David J. Salant, Sanjeev Sethi, Marianne Silkjaer, Wen‐Chao Song, Fabrizio Spoleti, Ronald P. Taylor, Nicole C. A. J. van de Kar, Cees van Kooten, Len Woodward, Yuzhou Zhang, Peter F. Zipfel, Marco Zuccato - Kidney International 2024 cited by 125

  7. Relative Role of Genetic Complement Abnormalities in Sporadic and Familial aHUS and Their Impact on Clinical Phenotype

    Authors: , , , , , , , , , , , , , , , , , - Clinical Journal of the American Society of Nephrology 2010 cited by 1,034

  8. Complement factor H binds malondialdehyde epitopes and protects from oxidative stress

    Authors: , , , , , , , , , , , , , , - Nature 2011 cited by 525

  9. Candida albicans Scavenges Host Zinc via Pra1 during Endothelial Invasion

    Authors: , , , , , , , , - PLoS Pathogens 2012 cited by 241

  10. Kallikrein Cleaves C3 and Activates Complement

    Authors: , , , , , , , , , , , , - Journal of Innate Immunity 2017 cited by 145

  11. Immune modulation by complement receptor 3-dependent human monocyte TGF-β1-transporting vesicles

    Authors: , , , , , , , , , , , , , , - Nature Communications 2020 cited by 61

  12. Concept Hierarchies for Database Integration in a Multidatabase System

    Authors: , , , - Conference on Management of Data, COMAD 1994 cited by 124

  13. Candida albicans Induces Cross-Kingdom miRNA Trafficking in Human Monocytes To Promote Fungal Growth

    Authors: , , , , , , , , , , , , , , , , , , , - mBio 2022 cited by 49

  14. The Protease SplB of Staphylococcus aureus Targets Host Complement Components and Inhibits Complement-Mediated Bacterial Opsonophagocytosis

    Authors: , , , , , , , , , , , , - Journal of Bacteriology 2021 cited by 47

  15. Complement Inhibitors in Clinical Trials for Glomerular Diseases

    Authors: , , , , , - Frontiers in Immunology 2019 cited by 116

  16. Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1/CFHR3 deficiency

    Authors: , , , , , , , - Blood 2007 cited by 356

  17. The yeast Candida albicans evades human complement attack by secretion of aspartic proteases

    Authors: , , , , , - Molecular Immunology 2009 cited by 173

  18. Secretion of soluble complement inhibitors factor H and factor H-like protein (FHL-1) by ovarian tumour cells

    Authors: , , , , , , , - British Journal of Cancer 2002 cited by 108

  19. Age-related macular degeneration associated polymorphism rs10490924 in ARMS2 results in deficiency of a complement activator

    Authors: , , , , , , , , , , , , , , , , , , , - Journal of Neuroinflammation 2017 cited by 100

  20. Deletion of Complement Factor H–Related Genes CFHR1 and CFHR3 Is Associated with Atypical Hemolytic Uremic Syndrome

    Authors: , , , , , , , , , , , , , - PLoS Genetics 2007 cited by 324

  21. Atypical aHUS: State of the art

    Authors: , , , , , , , , , , , , - Molecular Immunology 2015 cited by 298

  22. Sequence Variation of Candida albicans Sap2 Enhances Fungal Pathogenicity via Complement Evasion and Macrophage M2‐Like Phenotype Induction

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Advanced Science 2023 cited by 23

  23. An imbalance of human complement regulatory proteins CFHR1, CFHR3 and factor H influences risk for age-related macular degeneration (AMD)

    Authors: , , , , , , , , , , - Human Molecular Genetics 2010 cited by 204

  24. Deletion of Lys224 in regulatory domain 4 of Factor H reveals a novel pathomechanism for dense deposit disease (MPGN II)

    Authors: , , , , , , , , , , - Kidney International 2006 cited by 203